» Articles » PMID: 9777951

Specific K-ras2 Mutations in Human Sporadic Colorectal Adenomas Are Associated with DNA Near-diploid Aneuploidy and Inhibition of Proliferation

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1998 Oct 20
PMID 9777951
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies indicate that p21ras proteins mediate their multiple cell functions through interactions with multiple effectors and that the number of new effectors is growing. We recently reported that K-ras2 mutations in human colorectal adenomas were associated with chromosome instability and proliferation changes. In the present study, we extend these previous observations. Hereditary and multiple (n > or = 5) adenomas and adenomas with early cancer were excluded. Dysplasia was moderate in 91 cases and high in 25, and the median adenoma size was 1.5 cm. K-ras2 spectrum analysis was done by sequence-specific oligonucleotide hybridization using nuclear suspensions provided by analysis and sorting of multiparameter flow cytometry. In particular, tissue inflammatory cells were separated for DNA diploid tumors, whereas DNA aneuploid epithelial subclones were analyzed separately. K-ras2 mutations and DNA aneuploidy were both detected in 29 of 116 (25%) cases. DNA aneuploid index was in the near-diploid region in the majority of cases. DNA aneuploidy was strongly associated with G-->C/T transversions. An association was also found between low S-phase values and G-->A transitions. These findings were confirmed using multivariate logistic regression analysis to account for the effects of size, dysplasia, site, type, age, and sex. These data suggest that specific K-ras2 mutations in a subgroup of human sporadic colorectal adenomas play a role in chromosome instability and, contrary to expectations, are associated with inhibition of proliferation.

Citing Articles

The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target.

Brandl L, Kirstein N, Neumann J, Sendelhofert A, Vieth M, Kirchner T Med Oncol. 2018; 36(1):5.

PMID: 30460421 DOI: 10.1007/s12032-018-1225-1.


Generation, repair and replication of guanine oxidation products.

Kino K, Hirao-Suzuki M, Morikawa M, Sakaga A, Miyazawa H Genes Environ. 2017; 39:21.

PMID: 28781714 PMC: 5537945. DOI: 10.1186/s41021-017-0081-0.


Contiguous 2,2,4-triamino-5(2H)-oxazolone obstructs DNA synthesis by DNA polymerases α, β, η, ι, κ, REV1 and Klenow Fragment exo-, but not by DNA polymerase ζ.

Suzuki M, Kino K, Kawada T, Oyoshi T, Morikawa M, Kobayashi T J Biochem. 2015; 159(3):323-9.

PMID: 26491064 PMC: 4763079. DOI: 10.1093/jb/mvv103.


Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context.

Monticone M, Biollo E, Maffei M, Donadini A, Romeo F, Storlazzi C Mol Cancer. 2008; 7:92.

PMID: 19087308 PMC: 2615043. DOI: 10.1186/1476-4598-7-92.


Molecular pathology of well-differentiated thyroid carcinomas.

Sobrinho-Simoes M, Preto A, Rocha A, Castro P, Maximo V, Fonseca E Virchows Arch. 2005; 447(5):787-93.

PMID: 16189702 DOI: 10.1007/s00428-005-0065-5.


References
1.
van den Ingh H, Griffioen G, Cornelisse C . Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res. 1985; 45(7):3392-7. View

2.
Marra G, Boland C . Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst. 1995; 87(15):1114-25. DOI: 10.1093/jnci/87.15.1114. View

3.
Lengauer C, Kinzler K, Vogelstein B . Genetic instability in colorectal cancers. Nature. 1997; 386(6625):623-7. DOI: 10.1038/386623a0. View

4.
Giaretti W, Sciallero S, Bruno S, Geido E, ASTE H, Di Vinci A . DNA flow cytometry of endoscopically examined colorectal adenomas and adenocarcinomas. Cytometry. 1988; 9(3):238-44. DOI: 10.1002/cyto.990090309. View

5.
Giaretti W, Santi L . Tumor progression by DNA flow cytometry in human colorectal cancer. Int J Cancer. 1990; 45(4):597-603. DOI: 10.1002/ijc.2910450404. View